Patent · US Active

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

US9789132B2 · kind B2 · utility

0Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2016
Grant dateOct 17, 2017
Priority date—
Expiry dateOct 14, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.